Cases 31 - 40 of 61
Novo Nordisk Inc. et al v. Alvogen, Inc.
as 1:2022cv00299
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Alvogen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk A/S et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00296
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
as 1:2022cv00294
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Rio Biopharmaceuticals, Inc. and EMS S/A
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al
as 1:2022cv00297
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Sandoz Inc.
as 1:2020cv00747
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Healthcare AG et al v. Laboratoire Francais du Fractionnement et des Biotechnologies S.A. et al
as 1:2020cv00580
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk Healthcare AG
Defendant:
Laboratoire Francais du Fractionnement et des Biotechnologies S.A. and Hema Biologics, LLC
Cause Of Action: 35 U.S.C. § 271
NOVO NORDISK INC. et al v. SANDOZ INC.
as 1:2020cv06842
Plaintiff:
NOVO NORDISK INC. and NOVO NORDISK A/S
Defendant:
SANDOZ INC.
Cause Of Action: 35 U.S.C. § 271
NOVO NORDISK INC. et al v. SANDOZ INC.
as 3:2020cv06842
Plaintiff:
NOVO NORDISK INC. and NOVO NORDISK A/S
Defendant:
SANDOZ INC.
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Mylan Institutional LLC
as 1:2019cv00164
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
